Eradicating polio: Iran offers free vaccines to Pakistan, Afghanistan

Team of health and education officials to meet Saira Tarar


Sehrish Wasif June 16, 2015
PHOTO: AFP

ISLAMABAD: Iran is ready to offer free anti-polio vaccines to Pakistan and Afghanistan in an effort to help them effectively continue the fight against the disease.

An Iranian delegation comprising health ministry and medical education officials arrived on Monday for three days to explore options of extending cooperation to Pakistan.

The delegation is led by Dr Mohsin Asadi Lari, special assistant for international affairs to the health minister. Other delegates include Dr Mahmood Reza Miribanjar, Vice Chancellor for Zahidan Medical University in Iran and Dr Akbar Abdullahi Asal, head of Federal Drugs Regulatory Agency of Iran. The delegation also included Fereshte Zeraati, who is director of communicable diseases at the health ministry.

A senior official at the Ministry of National Health Services, Regulation, and Coordination (NHSRC) wishing not to be named, said the Iranian delegation will hold a meeting with Health Minister Saira Afzal Tarar. The delegation was expected to meet other international donor agencies on Tuesday (today) to offer its support as well.

The official pointed out that Pakistan and Afghanistan had recently been declared one epidemiological block in terms of the fight against polio. Against this background, Tehran wanted to support both countries to put an end to this crippling disease.

Since Iran produces a significant quantity of polio vaccines, it is keen to provide the same to both countries, most likely free of charge.

Published in The Express Tribune, June 16th, 2015. 

COMMENTS (4)

Rustam Chowki | 5 years ago | Reply @pakistani: Who gives anything for free when realpolitik is concerned ??
whitesky | 5 years ago | Reply Can't accept Iran's offer to displease Saudi monarchy.
VIEW MORE COMMENTS
Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ